6628 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Transcenta Holding Ltd. is a clinical stage global biopharmaceutical company, which engages in discovery, research, development, and manufacturing of differentiated antibody therapies in therapeutic areas with high unmet medical needs. It focuses on oncology, nephrology, and bone diseases. The firm also develops Immune Tolerance Breaking technology platform to build a diversified and risk-balanced pipeline of antibodies. The company was founded on August 20, 2010 and is headquartered in Suzhou, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6628 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company